Skip to main content

Humana Value Stock - Dividend - Research Selection

Humana

ISIN: US4448591028 , WKN: 856584

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Sector Update: Health Care Stocks Retreat Late Afternoon

2025-10-02
Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index shedding 0.4% a

Why Humana (HUM) Stock Is Trading Up Today

2025-10-02
Shares of health insurance company Humana (NYSE:HUM) jumped 6.4% in the afternoon session after the company provided a positive update on its Medicare star ratings and affirmed its full-year earnings guidance.

Humana stock rises after Medicare star ratings update

2025-10-02
Investing.com -- Humana Inc (NYSE:HUM) stock rose 7% on Thursday following the company’s update on Medicare star ratings, which showed progress in its strategic initiatives to improve performance metrics.

Humana’s Medicare Advantage star ratings slip for 2026

2025-10-02
Humana is giving investors an early look at stars data after a CMS slip-up led some information to be inadvertantly shared online. The results are in line with expectations but still unsatisfactory, Humana said.

Major health insurers scaling back Medicare Advantage offerings in 2026

2025-10-02
CVS Health's Aetna, Humana and UnitedHealth plan to scale back Medicare Advantage offerings in 2026 due to government reimbursement cuts and rising healthcare costs.

Humana Benefits From Rising Premiums Amid High Benefit Ratio

2025-10-02
HUM gains from rising premiums, Medicare growth and CenterWell expansion, but faces pressure from high benefit ratios and costs.

Evercore Notes Humana’s (HUM) Long-Term Earnings Growth Despite Medium-Term Uncertainty

2025-10-02
Humana Inc. (NYSE:HUM) ranks among the stocks with low beta that can beat market volatility. On September 22, Evercore ISI began coverage of Humana Inc. (NYSE:HUM) with an In Line rating and a $295 price target, emphasizing the company’s medium-term concerns as well as its potential for long-term earnings growth. Evercore ISI stated that “after […]

3 Safe-and-Steady Stocks for Long-Term Investors

2025-10-02
Stocks with low volatility can be a great foundation for a portfolio, especially for investors looking to reduce risk. While they don’t often make headlines, these companies provide consistency in an unpredictable market.

Why Humana (HUM) Shares Are Plunging Today

2025-10-01
Shares of health insurance company Humana (NYSE:HUM) fell 5.2% in the afternoon session after the company announced it will reduce the reach of its Medicare Advantage plans next year, citing rising costs. The health insurer will decrease its Medicare Advantage presence from 48 states to 46 and will cover 85% of U.S. counties, down from 89% this year. This decision comes as insurers face higher utilization of medical services and claim that government payments have not kept up with increasing cos

Molina Healthcare: Resilient Growth At A Value Multiple Amid Medicaid Headwinds

2025-10-01
Molina Healthcare offers value for defensive investors with Medicaid growth, attractive valuation and resilience to policy changes. Click for more on MOH stock.